Show Notes
For years, we've told AFib patients to cut the caffeine. But new data from the DECAF trial suggests that might be wrong. In this episode, we’re trying a new format: first, the highlights from my latest video, and then a podcast-exclusive deep dive. We’ll explore why coffee might stabilize the heart, break down the earlier CRAVE trial, and look at the nitty-gritty methodology that changes how we interpret these results. Let's dive in.
Stop stressing over every health detail & start living! My FREE 'Necessary Nine' PDF cuts through the noise, giving you the essential things you need for a healthy life.
➡️ Download Here: https://www.jrennickemd.com/necessaryninepdf
CHAPTERS:
00:00 - Intro: The New Format
00:01:31 - The DECAF Trial (Video Start)
00:02:32 - Why We Thought Coffee Was Bad
00:03:25 - Study Design
00:04:23 - Results: Coffee vs. Abstinence
00:05:34 - 3 Proposed Mechanisms
00:06:50 - Limitations (Video Version)
00:08:05 - Practical Takeaways
00:08:38 - Podcast Deep Dive: The CRAVE Trial
00:09:50 - PACs vs. PVCs
00:11:07 - Activity & Sleep Findings
00:12:10 - DECAF Methodology Details
00:15:20 - The Open Label Limitation
00:17:12 - Summary & Final Thoughts
SELECTED REFERENCES:
https://pubmed.ncbi.nlm.nih.gov/41206802/
https://pubmed.ncbi.nlm.nih.gov/24009307/
https://www.acc.org/Latest-in-Cardiology/Articles/2021/11/08/12/02/sun-8am-crave-aha-2021
Disclaimer
This podcast is for entertainment, education, and informational purposes only. The topics discussed should not solely be used to diagnose, treat , or prevent any condition. The information presented here was created with an evidence based approach, but you please keep in mind that science is always changing and at the time of listening to this there may some new data that makes this information incomplete or inaccurate. Always seek the advice of your personal physician or qualified health care provider for questions regarding any medical condition.
More from Building Lifelong Athletes
In this episode, I try to cut through the noise of the cholesterol debate and walk through 150 years of vascular science. From ancient mummies to modern genetics, we examine how lipidology reached its consensus, the response-to-retention hypothesis, why ApoB particle count matters more than LDL cholesterol mass, and what landmark clinical trials reveal about cardiovascular risk.
Was Ancel Keys a visionary pioneer of preventive cardiology or the villain who triggered our metabolic health crisis? In this episode, I pull back the curtain on the real science, the controversial 1953 graph, hidden trial data, and sugar industry influence. We explore where Keys was decades ahead of his time, where his model failed, and what his legacy teaches us about navigating scientific dogma in clinical practice today.
In this episode, I break down the underlying science of cholesterol, lipoproteins, and heart disease. We'll cut through the online noise and examine how cholesterol actually moves through your bloodstream, why particle count (ApoB) matters more than total cholesterol weight, how statins and other medications work at the cellular level, and how plaque forms in atherosclerosis. Everything you need to understand lipidology 101.
Welcome back to the trenches! In our final breakdown of the 2026 ACC/AHA lipid guidelines, we are unpacking the pharmacology toolbox. From statins and ezetimibe to PCSK9 inhibitors and the nuances of side effects like SAMS, I want to give you the practical, evidence-informed strategies we need for our patients. We are all just trying to navigate this together.